Shares of Creo Medical Group PLC (LON:CREO – Get Free Report) passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 29.30 ($0.39) and traded as low as GBX 26.50 ($0.35). Creo Medical Group shares last traded at GBX 26.75 ($0.36), with a volume of 192,610 shares.
Creo Medical Group Stock Performance
The company has a quick ratio of 2.19, a current ratio of 3.83 and a debt-to-equity ratio of 13.88. The company has a market cap of £96.78 million, a PE ratio of -382.14 and a beta of 0.86. The firm has a fifty day simple moving average of GBX 29.30 and a 200-day simple moving average of GBX 33.06.
About Creo Medical Group
Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope.
Featured Stories
- Five stocks we like better than Creo Medical Group
- Want to Profit on the Downtrend? Downtrends, Explained.
- Can Costco Stock Hit New Highs as Interest Rates Drop?
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- These 3 Stocks Show How to Navigate Declining Consumer Confidence
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy?
Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
